Immix Biopharma, Inc.
IMMX
$1.99
-$0.039-1.92%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -40.11% | -54.85% | -67.00% | -94.14% | -87.44% |
| Total Depreciation and Amortization | 1,998.18% | 2,473.33% | 2,295.45% | 1,276.19% | 150.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.51% | 95.85% | 167.25% | 239.52% | 283.96% |
| Change in Net Operating Assets | 140.04% | 2,746.27% | 226.35% | 323.45% | 746.72% |
| Cash from Operations | -28.35% | -25.39% | -35.30% | -63.71% | -53.50% |
| Capital Expenditure | -2,160.46% | -1,657.58% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2,160.46% | -1,657.58% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.74% | 10.70% | 454.11% | 30,090.38% | 432.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -112.58% | -115.44% | -112.73% |
| Cash from Financing | 3.14% | 8.07% | 408.16% | 7,057.64% | 378.44% |
| Foreign Exchange rate Adjustments | -110.91% | 3,420.00% | 280.00% | 178.91% | 204.76% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -95.77% | -95.95% | 296.94% | 335.03% | 196.80% |